Risperidone
| Subclass of | heterocyclic compound |
|---|---|
| Part of | response to risperidone |
| Get use | Medication |
| Stylized name | risperiDONE, RisperDAL |
| Chemical formula | C₂₃H₂₇FN₄O₂ |
| Canonical SMILES | CC1=C(C(=O)N2CCCCC2=N1)CCN3CCC(CC3)C4=NOC5=C4C=CC(=C5)F |
| Active ingredient in | Risperdal |
| World Health Organisation international non-proprietary name | risperidone |
| Legal status (medicine) | boxed warning |
| Pregnancy category | Australian pregnancy category B3, US pregnancy category C |
| LiverTox likelihood score | LiverTox toxicity likelihood category C |
Risperidone, dem sell under de brand name Risperdal among odas, be an atypical antipsychotic[1] dem use to treat schizophrenia den bipolar disorder,[1] as well as aggressive den self-injurious behaviors wey be associated plus autism spectrum disorder.[2] Dem dey take am either by mouth anaa by injection (i.e., subcutaneous anaa intramuscular).[1] De injectable versions be long-acting den dey last for 2–4 weeks.[3]
Common side effects dey include weight gain, drowsiness, fatigue, insomnia, dry mouth, constipation, elevated prolactin levels, den restlessness.[1][4] Serious side effects fi include de potentially permanent movement disorder tardive dyskinesia, as well as neuroleptic malignant syndrome, an increased risk of suicide, den high blood sugar levels.[1][3] Insyd older people plus psychosis as a result of dementia, e fi increase de risk of death.[1] E be unknown if e be safe for use insyd pregnancy.[1] Ein mechanism of action no be entirely clear, buh dem dey believe to be related to ein action as a dopamine den serotonin antagonist.[1]
Study of risperidone begin insyd de late 1980s wey dem approve for sale insyd de United States insyd 1993.[1][5][6] E be on de World Health Organization's List of Essential Medicines.[7] E be available as a generic medication.[3] Insyd 2023, e be de 176th most commonly prescribed medication insyd de United States, plus more dan 2 million prescriptions.[8][9]
References
[edit | edit source]- 1 2 3 4 5 6 7 8 9 "Risperidone". The American Society of Health-System Pharmacists. Archived from the original on 2 December 2015. Retrieved 1 December 2015.
- ↑ Schatzberg AF, Nemeroff CB (2009). The American Psychiatric Publishing textbook of psychopharmacology (4th ed.). Washington, D.C.: American Psychiatric Pub. p. 627. ISBN 978-1-58562-309-9.
- 1 2 3 Hamilton R (2015). Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. pp. 434–435. ISBN 978-1-284-05756-0.
- ↑ Hasnain M, Vieweg WV, Hollett B (July 2012). "Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians". Postgraduate Medicine. 124 (4): 154–67. doi:10.3810/pgm.2012.07.2577. PMID 22913904. S2CID 39697130.
- ↑ Schatzberg AF, Nemeroff CB (2009). The American Psychiatric Publishing textbook of psychopharmacology (4th ed.). Washington, D.C.: American Psychiatric Pub. p. 627. ISBN 978-1-58562-309-9.
- ↑ "Risperdal- risperidone tablet Risperdal M-Tab- risperidone tablet, orally disintegrating Risperdal- risperidone solution". DailyMed. Archived from the original on 30 April 2017. Retrieved 31 December 2019.
- ↑ World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. 2019. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ↑ "The Top 300 of 2023". ClinCalc. Archived from the original on 12 August 2025. Retrieved 13 August 2025.
- ↑ "Risperidone Drug Usage Statistics, United States, 2014 - 2023". ClinCalc. Retrieved 13 August 2025.
Read further
[edit | edit source]- Dean L (2017). "Risperidone Therapy and CYP2D6 Genotype". In Pratt VM, McLeod HL, Rubinstein WS, et al. (eds.). Medical Genetics Summaries. National Center for Biotechnology Information (NCBI). PMID 28520384. Bookshelf ID: NBK425795.
External links
[edit | edit source]- Commons category link from Wikidata
- Alpha-1 blockers
- Alpha-2 blockers
- Antiaggressive drugs
- Atypical antipsychotics
- Drugs wey Schering-Plough develop
- Belgian inventions
- Fluoroarenes
- Galactagogues
- H1 receptor antagonists
- Hallucinogen antidotes
- Drugs wey Johnson & Johnson develop
- Janssen Pharmaceutica
- Lactams
- Mood stabilizers
- Piperidinylbenzisoxazoles
- Prolactin releasers
- Pyrimidones
- Serotonin receptor antagonists
- Treatment of autism
- World Health Organization essential medicines
- Translated from MDWiki